ResearchSite 

  CCI/IRB

 
 

 About CCI

 
 

 FAQs to CCI

 
 

 CCI Policy Manual

 
 

 Education--CITI Program

 
 

 Scientific Review Process

 
 

 Scientific Reviewers

 
 

 Scientific Review Form

 
 

 CCI/IRB Forms

 
 

 CTPro

 
 

 IRB Review Committee

 
 

 Additional Links

 
  

  Human Subject Protection

 
   
  
Print Friendly Version Help and Support
  Research Home

CCI FAQ Information

Frequently Asked CCI Questions

Nature of Question

CCI Staff Member or Chair

Email

Telephone

CCI jurisdiction: 

         When is an investigator required to                submit to our IRB

         What kind of review is required

Mary Williams

mwillia2@bidmc.harvard.edu

 

7-3743

Meeting attendance and/or presentation

Susan Yuen-Lee -- West campus

Astrid Joseph -- East campus

Lily Moy -- Continuing review

syuenle@bidmc.harvard.edu

ajoseph3@bidmc.harvard.edu

lmoy@bidmc.harvard.edu 

7-1831

7-1827

7-4311

Submission of new applications

(Including questions about informed consent)

Susan Yuen-Lee

Astrid Joseph

syuenle@bidmc.harvard.edu

ajoseph3@bidmc.harvard.edu

7-1831

7-1827

Continuing review

Lily Moy

lmoy@bidmc.harvard.edu

7-4311

Educational Requirements

Michael D'Egidio

CITIexam@bidmc.harvard.edu.

7-4524

Emergency Use requests

 

**page Alan Lisbon ASAP at 32181

Mary Williams

Susan Yuen-Lee

Astrid Joseph

Lily Moy

mwillia2@bidmc.harvard.edu

syuenle@bidmc.harvard.edu

ajoseph3@bidmc.harvard.edu

lmoy@bidmc.harvard.edu 

7-3743

7-1831

7-1827

7-4311

Publicity: 

What are the CCI requirements for advertising for recruitment, press releases, speaking directly with the press

Astrid Joseph

ajoseph3@bidmc.harvard.edu

7-1827

Investigational Drugs/Devices: 

What kinds of approvals are required for use in clinical trials

Mary Williams

mwillia2@bidmc.harvard.edu

 

7-3743

Reporting of adverse events, deviations, or other audit/compliance issues, regulatory documents, monitoring and special reporting questions

Mary Williams

mwillia2@bidmc.harvard.edu

 

7-3743

Clinical Trials registration on Clinicaltrials.gov

Annette Douglin

adouglin@bidmc.harvard.edu

7-4113

Research involving vulnerable populations:  children, pregnant women, neonates, fetuses, individuals with diminished mental/cognitive capacity

Dan DeHainaut

  ddehaina@bidmc.harvard.edu

7-4097

Industry contracts, budgets, NOGAs and final IRB approval

Susan Yuen-Lee

syuenle@bidmc.harvard.edu

 

7-1831

Research subject complaints

K. Babu Krishnamurthy

bkrishna@bidmc.harvard.edu

 

7-4088

 

 

 

 

Copyright 2009 Beth Israel Deaconess Medical Center | Contact Research Webmaster

IP Address: 38.107.191.81   |  Web Server: research.bidmc.harvard.edu   |  Database Server: Colorado\SQL17   |  App Path: /OST/CCI/CCIFAQ.asp   |  Version:

Browser: CCBot/1.0 (+http://www.commoncrawl.org/bot.html)
SecurityGroup: